Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 1/20 | 0.44 |
| ▸ | CNR2 | P34972 | 5/20 | 0.43 |
| ▸ | PLAU | P00749 | 2/20 | 0.41 |
| ▸ | F12 | P00748 | 1/20 | 0.41 |
| ▸ | NCF1 | P14598 | 1/20 | 0.41 |
| ▸ | NOS3 | P29474 | 1/20 | 0.41 |
| ▸ | NOS1 | P29475 | 1/20 | 0.41 |
| ▸ | NOS2 | P35228 | 1/20 | 0.41 |
| ▸ | BACE1 | P56817 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | PLG | P00747 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | CFTR | P13569 | 1/20 | 0.37 |
| ▸ | GOPC | Q9HD26 | 1/20 | 0.37 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.36 |
| ▸ | S100A4 | P26447 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18576588 | 0.84 | CYP2A6 (0.52) | CYP2A6CNR2PLAUF12NCF1 | |
| SCHEMBL20862876 | 0.83 | CYP2A6 (0.43) | CYP2A6CNR2PLAUF12NCF1 | |
| SCHEMBL8250524 | 0.78 | CYP2A6 (0.52) | CYP2A6CNR2PLAUF12NCF1 | |
| SCHEMBL18950546 | 0.77 | CYP2A6 (0.44) | CYP2A6CNR2PLAUF12NCF1 | |
| SCHEMBL25482213 | 0.75 | CYP2A6 (0.53) | CYP2A6CNR2PLAUF12NCF1 | |
| SCHEMBL18533190 | 0.75 | PLAU (0.44) | CYP2A6CNR2PLAUF12NCF1 | |
| SCHEMBL24549910 | 0.74 | CYP2A6 (0.44) | CYP2A6CNR2PLAUF12NCF1 | |
| SCHEMBL20363014 | 0.74 | CNR2 (0.33) | CYP2A6CNR2PLAURAB9APLG | |
| SCHEMBL349832 | 0.74 | CNR2 (0.56) | CYP2A6CNR2PLAUF12NCF1 | |
| SCHEMBL29094378 | 0.74 | RAB9A (0.49) | CYP2A6CNR2PLAUF12NCF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10847727-B2 | Compositions for electronic devices | MERCK PATENT GMBH (DE) | 2020-11-24 | — | — | US | disclosed |
| US-20200176693-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2020-06-04 | — | — | US | disclosed |
| US-10230060-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2019-03-12 | — | — | US | disclosed |
| US-20180145267-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2018-05-24 | — | — | US | disclosed |
| US-20170141328-A1 | COMPOSITIONS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2017-05-18 | — | — | US | disclosed |
| US-9577201-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2017-02-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170141328-A1 | COMPOSITIONS FOR ELECTRONIC DEVICES | EFNA1, EPHA6, EPHB6 | CYP2A6 1120/4885CNR2 3572/4885PLAU 2543/4885 |
| US-20200176693-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | RUVBL2, TERT, OR10J3 | CYP2A6 4349/4885CNR2 2725/4885PLAU 4062/4885 |
| US-20180145267-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | PIEZO1, ORAI2, ICMT | CYP2A6 4414/4885CNR2 4809/4885PLAU 635/4885 |
| US-10847727-B2 | Compositions for electronic devices | EFNA1, EPHA6, EPHB6 | CYP2A6 1120/4885CNR2 3572/4885PLAU 2543/4885 |
| US-10230060-B2 | Organic electroluminescent materials and devices | RUVBL2, OR10J3, EML4 | CYP2A6 3435/4885CNR2 2833/4885PLAU 4263/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.